Correction: Mosca et al. Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response. Cancers 2022, 14, 3414

Key Points

• The study aims to address the impact of MHC-I haplotype on the CD8+ T cell response against tumors in sarcoma.
• Correction of prior data regarding MHC-I haplotype
• Analysis of CD8+ T cell activation
• Assessment of the immune response to tumors
• Confirmed MHC-I haplotype restricts tumor-specific CD8+ T cell activity
• Identified implications for tumor immune evasion
• Provided insights into sarcoma immunity